Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
about
Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloridePreparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment.Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.
P2860
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@ast
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@en
type
label
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@ast
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@en
prefLabel
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@ast
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@en
P2860
P356
P1476
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
@en
P2093
K Swetha Goud
P2860
P304
P356
10.4103/0250-474X.100234
P577
2011-11-01T00:00:00Z